Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04970368 · ClinicalTrials.gov registry record · Phase 3
Comparison of Nodal Staging in Endometrial Cancer
A Phase 3 study, sponsored by Frederick R. Ueland, M.D..
- Terminated
- Registry status
- Phase 3
- Development phase
- 38
- Enrollment target
NCT04970368: Clinical Trial Phase 3 study, sponsored by Frederick R. Ueland, M.D..
NCT04970368 is a Phase 3 study that was terminated before completion, run by Frederick R. Ueland, M.D.. The registered enrollment target is 38 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04970368, a Phase 3 study, was terminated before completion, sponsored by Frederick R. Ueland, M.D..
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging.
Primary Outcome
Recurrence-free survival rate in women with endometrial cancer treated with selective versus sentinel node surgical staging
Interventions
- PROCEDURE Sentinel node procedure
- PROCEDURE Selective staging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2023-06-13 |
| Phase | Phase 3 |
Why NCT04970368 stopped before completion
NCT04970368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Sentinel node procedure is the first listed.
NCT04970368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04970368 about?
NCT04970368 is a clinical study titled "Comparison of Nodal Staging in Endometrial Cancer". This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging.
What is the current status of trial NCT04970368?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 38 participants. The study started on 2021-11-05. Estimated completion is 2023-06-13.
What interventions are being tested in trial NCT04970368?
The interventions under investigation include: Sentinel node procedure (PROCEDURE), Selective staging (PROCEDURE).
Who is sponsoring clinical trial NCT04970368?
This trial is sponsored by Frederick R. Ueland, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04970368's enrollment target sits among peer trials
38 1900th of 2000 higher than 100 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI